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The phosphoprotein (P) of vesicular stomatitis virus (VSV) is an essential subunit of the viral RNAdependent RNA polymerase (RdRp) complex. It is phosphorylated at two different domains. Using defective
interfering (DI) RNA or minigenomic RNA templates, we previously demonstrated that phosphorylation within
the amino-terminal domain I is essential for transcription, whereas phosphorylation within the carboxyterminal domain II is necessary for replication. For the present study, we examined the role of the phosphorylation of residues in these domains in the life cycle of VSV. Various mutant P coding sequences were inserted
into a full-length cDNA clone of VSV, and the virus recovery, kinetics of growth, and mRNA and protein
synthesis were examined. We observed that virus recovery was completely abolished when all three phosphate
acceptor sites in domain I or both sites in domain II were replaced with alanine. Single or double mutations
in domain I (with the exception of P60/64) or single mutations in domain II had no adverse effect on virus
recovery. VSVP227, carrying alanine at position 227, showed reduced kinetics of virus growth but increased
kinetics of viral mRNA synthesis in infected cells. More interestingly, this particular virus exhibited a
significantly reduced cytopathic effects and apoptosis in infected cells, implying that P may be involved in these
processes. Furthermore, we found that DI RNAs of different sizes were generated by high-multiplicity passaging of various mutant VSVs, indicating that the viral RdRp may play a significant role in the process of DI
particle generation. Taken together, our results suggest that the phosphorylation of residues in domains I and
II of VSV P is indispensable for virus growth.
extreme carboxy-terminal region, domain III, spans 21 to 25
residues and contains a number of basic residues. A hypervariable region (called a hinge) of approximately 50 to 60 amino
acids is located between domains I and II, but its function is
unknown.
The importance of phosphorylation in domain I of the P
protein for transcription was elucidated by several in vitro
transcription reconstitution studies (1, 3). Purified P protein
expressed in Escherichia coli is neither phosphorylated nor
active in transcription. In the presence of cellular casein kinase
II, it becomes phosphorylated and functions in transcription in
vitro (2, 22). By mutational and biochemical studies, the phosphate acceptor sites were mapped to Ser-59 and Ser-61 in PNJ
and Ser-60, Thr-62, and Ser-64 in PI (6, 53, 54). Further studies
suggested that the phosphorylation of these residues results in
multimerization of the P protein, which in turn facilitates its
binding to the L protein for transcription (7, 16, 17). Using a
plasmid-based reverse genetics system (46), we demonstrated
that the phosphorylation of these residues is critical for the
function of the P protein in transcription but not in replication
(44). In that study, we showed that a P protein in which all of
the phosphate acceptor sites were altered to alanine was only
marginally active in transcription. Alteration of these residues
to glutamic acid or aspartic acid led to proteins that were as
active as the wild-type (wt) protein in transcription, suggesting
that a net negative charge in the region as a result of phosphorylation is crucial for transcriptional activation of the
protein (44). A separate study also reported low levels of
transcription under in vitro conditions with the same phosphorylation-defective P mutant (53).
The phosphorylation sites in domain II have been mapped to

Vesicular stomatitis virus (VSV) is the prototypic rhabdovirus and has a negative-stranded RNA genome of 11,161 nucleotides (50). Within the virus and in infected cells, the
genomic RNA is tightly encapsidated by the nucleocapsid (N)
protein, forming the viral nucleocapsid, which serves as the
template for transcription and replication by the associated
viral RNA-dependent RNA polymerase (RdRp) (50). The
RdRp is a complex that contains the virally encoded large (L)
protein and the phosphoprotein (P protein). While the L protein contains the catalytic center for the polymerization of
nucleotides, the P protein serves as an essential subunit of the
RdRp. The P protein is multifunctional: in addition to playing
a major role in polymerase functions, it binds to the L protein
and stabilizes it from proteolytic degradation (5, 12), it complexes with the newly synthesized N protein for the efficient
encapsidation of nascent RNA (9, 39, 48), and it interacts with
terminal sequences of the viral genome for viral RNA synthesis
(27, 29).
Through mutational and biochemical studies, three functionally homologous domains have been identified in the P
proteins (Fig. 1A) of both the Indiana (PI) and New Jersey
(PNJ) serotypes of VSV (20, 47). The amino-terminal domain
I (residues 1 to approximately 150) is highly acidic and phosphorylated. Domain II, in the carboxy-terminal region spanning residues 210 to about 244, is also phosphorylated. The
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Vine St., Lincoln, NE 68588-0666. Phone: (402) 472-1067. Fax: (402)
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FIG. 1. (A) Domain structure of P protein. The P protein, with three functionally defined domains (I, II, and III) and a hinge region, is shown.
The phosphate acceptor sites Ser-60, Ser-64, Ser-226, and Ser-227 are indicated by solid circles and Thr-62 is indicated by a solid square.
(B) Various P protein domain I mutants used for the present study. Substitutions of alanine (A) and glutamic acid (E) residues for serine (S) and
threonine (T) residues in domain I are shown. (C) Domain II P protein mutants. (D) Genome organization of VSV. The protein coding regions
of VSV genes N, P, M, G, and L are shown in rectangular boxes. E, EcoRV sites flanking the P gene.

Ser-236 and Ser-242 in PNJ and Ser-226 and Ser-227 in PI (6).
For PNJ, domain I residues must be phosphorylated prior to
the phosphorylation of domain II residues (3), but for PI,
domain II residues can be phosphorylated without the prior
phosphorylation of domain I residues (6). Since phosphorylation in domain I is essential and sufficient for transcription, it
seems that the phosphorylation of domain II may not be involved in transcription (16, 38). This contention is further
supported by the demonstration that mutations at the domain
II phosphate acceptor sites do not affect the transcription functions of the P protein, although its function in replication is
severely compromised (26). Most recently, Gupta et al. (23)
observed that a transcriptionally inactive P mutant can still
form a tripartite complex with the N and L proteins and can
function as a replicase for the synthesis of full-length genomic
RNA. This study, along with other studies (8, 26, 44), suggests
that the transcriptase and replicase complexes of VSV are two
distinct entities.
Phosphorylation of the P protein may also play a role in the
virus life cycle, during which an infectious unit is assembled in
an orchestrated manner involving the transcription, replication, and assembly of functional nucleocapsid templates. Since
the P protein interacts with the terminal sequences of the viral
genome (27, 29), mutations at the phosphorylation sites might
alter such interactions. In the context of the full-length viral
genome, such altered polymerase interactions might result in
reduced viral growth and potentially lead to the generation of
different types of defective interfering (DI) particles. In the
case of respiratory syncytial virus (RSV), mutations at the P
phosphorylation sites led to highly impaired growth of the virus
in animals, although such mutations had mixed effects on the in
vitro replication of RSV in different cell types (36). On the
other hand, phosphorylation-defective mutants of Sendai virus
(SeV) and the wt virus showed no significant differences in
growth in cell culture and in mice (25).
For the present study, we examined whether infectious VSV
particles containing mutations in the phosphate acceptor sites
could be recovered. Our results show that VSV particles containing mutations in phosphate acceptor sites Ser-60, Thr-62,

and Ser-64 or in Ser-60 and Ser-64 in domain I of the P protein
could not be recovered, although VSV particles containing all
other combinations of mutations were readily recovered. Single mutations at residue Ser-226 or Ser-227 in domain II also
led to the generation of infectious viruses. However, mutations
at both of these residues were detrimental. Furthermore, we
observed that VSV particles containing a mutation at residue
227 (VSVP227) were less cytopathic and induced an increased
synthesis of mRNAs in infected cells compared to wt VSV.
MATERIALS AND METHODS
Cells and viruses. The baby hamster kidney (BHK-21) cells used for this study
were maintained in Eagle’s minimal essential medium (MEM) containing 5%
fetal bovine serum (FBS). VSV (Indiana serotype, San Juan strain) was propagated in BHK-21 cells for the preparation of virus stock. A recombinant vaccinia
virus (vTF7-3) expressing bacteriophage T7 RNA polymerase (15) was grown
and titrated by plaque assay in BHK-21 cells. The production and purification of
DI T particles (33) were described previously (46).
Plasmids. The plasmids pN, pP, and pL, carrying the coding sequences of the
N, P, and L proteins of VSV (Indiana serotype, San Juan strain) under the
control of the T7 RNA polymerase promoter, as well as plasmid pVSVFL(⫹),
containing an antigenomic-sense full-length VSV sequence (a gift of J. K. Rose,
Yale University, New Haven, Conn.), have been described previously (32, 46).
The plasmids encoding the mutant P proteins of VSV (Indiana serotype, MuddSummers strain) have been described in previous studies (26, 44). Additional P
protein mutants were generated by PCR-based mutagenesis performed by the
megaprimer method (52). The mutant P genes were amplified from their respective plasmids by using Pfu polymerase (Stratagene). The primers used for amplification were as follows: P(⫹), 5⬘ATATATGGTACCGATATCATGGATAA
TCTCACAAAAGTTCGTGAG3⬘(forward), and P(⫺), 5⬘ATATATCTGCAGA
TATCTGTTACTTTTTTTCATAGTCTACAGAGAATATTTG3⬘ (reverse),
both of which contain EcoRV sites (underlined). The PCR product was purified,
digested with EcoRV, and cloned into pVSVFL(⫹) that had been digested with
the same enzyme. Clones were sequenced by cycle sequencing for the presence
of the designed mutations in the P gene.
Transfection, recovery, and identification of mutant viruses. BHK-21 cells
were grown in 60-mm-diameter tissue culture dishes to 80 to 90% confluency.
The cells were infected with vTF7-3 at a multiplicity of infection (MOI) of 10
PFU/cell. After adsorption for 45 min at 37°C, the cells were washed and
transfected with 4 g of pVSVFL(⫹), 6 g of pN, 2 g of pL, and 4 g of a wt
or mutant pP plasmid by using Lipofectamine 2000 (Invitrogen). At 4 h posttransfection, the cells were washed twice and incubated with 2 ml of fresh
medium containing 5% FBS for 48 h. Culture supernatants were harvested,
clarified at 16,000 ⫻ g for 20 min, and used to infect fresh BHK-21 cells for 14
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to 18 h to generate stock viruses. Rescued viruses in the culture supernatants
from transfected cells and the amplification passage (P1) were titrated by plaque
assays. Stocks of mutant viruses were prepared by infecting BHK-21 cells with P1
viruses at an MOI of 0.1. For confirmation of the identities of the mutant viruses,
BHK-21 cells were infected with each virus at an MOI of 10. At 6 h postinfection,
total RNAs from the cells were isolated by using TRIzol (Invitrogen). Reverse
transcription-PCR (RT-PCR) was performed with Moloney murine leukemia
virus reverse transcriptase and Taq DNA polymerase (Invitrogen). PCR products
were analyzed in agarose gels and sequenced directly for the presence of the
mutations. For sequencing of the P gene of the mutant viruses in its entirety, the
RT-PCR products were cloned into pBR322 and five clones of each mutant were
sequenced.
Determination of single-step growth kinetics. BHK-21 cells were grown in
60-mm-diameter tissue culture dishes to 90% confluency. Cells were infected
with either wt or mutant virus at an MOI of 20. After adsorption for 45 min, the
cells were washed twice with phosphate-buffered saline, and 2.5 ml of fresh
medium containing 2% FBS was added. Aliquots of 120 l of culture supernatant
were collected at various times postinfection, clarified at 16,000 ⫻ g for 5 min,
and frozen at ⫺85°C. The amount of virus present in the culture supernatant was
determined by plaque assay.
High-multiplicity passaging of mutant viruses. BHK-21 cells were grown in
60-mm-diameter tissue culture dishes to 90% confluency. The cells were infected
with wt and mutant viruses at an MOI of 10. The cells were incubated at 37°C,
and the development of a cytopathic effect (CPE) was monitored for a period of
12 to 24 h. When complete CPE developed, the culture supernatant was harvested and clarified. One hundred microliters of the clarified supernatant from
this passage (P1) was used to infect fresh BHK-21 cells as described above. At 16
to 20 h postinfection, 100 l of clarified supernatant from the next passage (P2)
was used to infect fresh BHK-21 cells. The process of high-multiplicity passaging
was repeated multiple times to generate P3 to P10 supernatants. Supernatants
from each passage were clarified and stored in small aliquots at ⫺85°C until
further use.
Metabolic labeling of viral RNAs and electrophoretic analysis. BHK-21 cells
were grown in 35-mm-diameter tissue culture dishes to 90% confluency. Cells
were infected with a wt or mutant virus at an MOI of 10 or 100. For an
examination of mRNA synthesis at early times after infection, cells infected with
the higher MOI were treated with actinomycin D at a concentration of 20 g per
ml for 1 h immediately after infection and the RNAs were radiolabeled with 25
Ci each of [3H]uridine and [3H]adenosine per ml of Dulbecco’s modified Eagle
medium for 1 h in the presence of actinomycin D. For an examination of mRNA
synthesis at late times after infection, cells infected with the lower MOI were
treated and labeled similarly at 7 to 8 h postinfection. After labeling, total RNAs
from the cells were extracted by the use of TRIzol, analyzed by electrophoresis
in acid agarose-urea gels, and detected by fluorography as described earlier (46).
The fluorograms were scanned and RNA bands were quantitated with the VersaDoc imaging system and Quantity One software (Bio-Rad).
To analyze viral RNA synthesis in cells infected with culture supernatants from
high-multiplicity passages, we infected BHK-21 cells grown as described above
with an equal volume of cell culture supernatant collected from each passage.
After 45 min of adsorption, the cell monolayers were washed and incubated in
medium. The infected cells were labeled for 4 h with [3H]uridine and [3H]adenosine in the presence of actinomycin D as described above. Cytoplasmic extracts
were prepared as described previously (46) and total RNAs recovered from
one-third of the extracts were analyzed as described above. For analysis of the
replication products, the viral nucleocapsids were immunoprecipitated from the
remaining cytoplasmic extracts, and RNAs recovered from the immunoprecipitated nucleocapsids were analyzed as described above.
Analysis of viral proteins. BHK-21 cells grown in 35-mm-diameter tissue
culture dishes to 90% confluency were infected with a wt or mutant virus at an
MOI of 10 or 100. For an examination of protein synthesis at early times after
infection, cells infected with the higher MOI were incubated with methionineand cysteine-free Dulbecco’s modified Eagle medium for 1 h immediately after
infection and the proteins were radiolabeled with 30 Ci of Expre35S35S label
(Perkin-Elmer) per ml of medium. For an examination of protein synthesis at
late times after infection, cells infected with the lower MOI were labeled similarly at 7 to 8 h postinfection. After labeling, cell lysates were prepared, and the
viral proteins were analyzed by electrophoresis in 10% polyacrylamide gels and
detected by fluorography as described earlier (46).
To examine the phosphorylation status of P proteins, we infected parallel
cultures of BHK-21 cells grown as described above with a wt or mutant virus at
an MOI of 10. For orthophosphate labeling, infected cells were incubated with
phosphate-free medium for 1 h prior to labeling with 100 Ci of [32P]orthophosphate (Perkin-Elmer) per ml of medium. Equal amounts of cell lysates from
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labeled and unlabeled cells were analyzed by electrophoresis as described above.
Gels containing radiolabeled proteins were subjected to autoradiography for the
detection of 32P-labeled P proteins. Equal quantities of cytoplasmic extracts from
labeled and unlabeled cells were electrophoresed in parallel 10% polyacrylamide
gels. The gel containing labeled samples was fixed, dried, and exposed for
autoradiography. The gel containing unlabeled samples was subjected to Western blotting. The blots were incubated with rabbit anti-P polyclonal antisera and
the protein bands were detected by chemiluminescence by use of an ECL kit
(Amersham). The protein or 32P content was quantitated with Quantity One
software as described above.
Apoptosis assay. BHK-21 cells grown in 35-mm-diameter tissue culture dishes
to 90% confluency were infected with a wt or mutant virus at an MOI of 0.5.
After adsorption for 45 min, the cells were washed, fresh medium was added, and
the cells were incubated at 37°C for 12 to 14 h. The medium was aspirated and
the cells were trypsinized. The cells were washed twice in cold phosphatebuffered saline and adjusted to a density of 106 per ml in 1⫻ annexin-binding
buffer (Molecular Probes). A 100-l cell suspension was mixed with 5 l of
annexin V-fluorescein isothiocyanate and 1 l of propidium iodide (100 g/ml)
(Molecular Probes) and incubated at room temperature for 15 min. Finally, the
cells were diluted with 400 l of 1⫻ annexin-binding buffer and analyzed by flow
cytometry for live, apoptotic, and necrotic cells.
Indirect immunofluorescence. BHK-21 cells were infected with an MOI of 0.5
of wt VSV or VSVP227. At 12 to 14 h postinfection, the cells were fixed with
acetone-methanol (1:1) at ⫺20°C and incubated with a polyclonal mouse antiVSV antibody. The cells were incubated with the secondary antibody, anti-mouse
Alexa-488 (Molecular Probes), and analyzed for immunofluorescence under a
Nikon fluorescence microscope attached to a camera (Optronics).

RESULTS
To determine the role of the phosphorylation of residues in
domains I and II of the P protein (Fig. 1A) of VSV in the virus
replication cycle, we wanted to recover VSVs encoding single
and multiple substitutions in the phosphate acceptor sites (Fig.
1B and C) of the P protein. We replaced the P protein coding
region in pVSVFL(⫹) (32) with various mutant P protein
coding regions. This was facilitated by the use of EcoRV sites
that flank the coding region of the P protein in pVSVFL(⫹)
(Fig. 1D). Mutations within the P coding region in various
pVSVFL(⫹) plasmids were confirmed by sequencing. Plasmids
encoding various mutant P proteins in pVSVFL(⫹) were then
used along with three support plasmids (pN, pP, and pL) to
recover various mutant VSVs by established procedures (32,
43, 45). Viruses encoding wt or mutant P proteins were designated VSVPwt, VSVP60, VSVP62, VSVP64, etc.
Recovery of VSVs containing mutant P proteins with single
or double amino acid substitutions at the phosphorylation
sites in domain I. For initial transfection experiments, we used
various mutant P plasmids as a component of a support plasmid mix to recover VSV; however, we were unable to recover
VSV from the transfected cells. This was most likely due to the
intrinsic low transcriptional activities of these mutant P proteins (44). We rationalized that the use of the wt P plasmid in
the support plasmid mix would likely drive the transcription
and replication of VSVFL templates at levels that would allow
us to initially recover viruses from the transfected cells. Subsequent infection and replication of the virus produced from
transfected cells would be dependent upon the activity of the
encoded mutant P proteins. Therefore, to recover VSV containing a wt or mutant P gene, we transfected BHK-21 cells
infected with vTF7-3 with various pVSVFL templates along
with the support plasmids pN, pP, and pL. The supernatants
from transfected cells were collected at 48 h posttransfection.
To determine if infectious VSV was present in the supernatant,
we used an aliquot of clarified supernatant to infect fresh
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FIG. 2. (A) Yield of various mutant viruses. BHK-21 cells were infected with mutant viruses at an MOI of 1, and the yield of virus in clarified
supernatants from infected cells at 16 h postinfection was determined by plaque assay. Error bars showing standard deviations for five independent
experiments are shown. (B) Single-cycle growth kinetics of viruses with substitutions in domain I residues. BHK-21 cells were infected with wt or
mutant viruses at an MOI of 20, and culture supernatants were collected at the indicated time points. The viruses in the supernatants were
quantitated by plaque assay. The averages of three independent experiments are presented. (C) Analysis of VSV mRNAs in cells infected with
domain I mutants. BHK-21 cells were infected with VSVPwt, VSVP60, VSVP62, and VSVP64 at an MOI of 10. RNAs were radiolabeled at 7 to
8 h postinfection in the presence of actinomycin D, analyzed by electrophoresis, and detected by fluorography as described in Materials and
Methods. The positions of the VSV mRNAs are indicated on the right. Numbers at the bottom show the average levels of mRNA from three
independent experiments. (D) Confirmation of identity of mutant viruses. Total RNAs isolated from wt or mutant virus-infected cells were
subjected to RT-PCR amplification of the P coding region. The products were directly sequenced by cycle sequencing. A chromatogram showing
the presence of the desired mutations is presented. Specific nucleotide changes corresponding to the mutant proteins are marked with arrowheads.

BHK-21 cells. The CPE that is characteristic of VSV infections
(the rounding of cells and subsequent detachment) was observed within 12 to 24 h postinfection, indicating that infectious VSV was present in the supernatant of transfected cells.
In control experiments in which the pL plasmid was omitted
from the support plasmid mix, no such CPE was detected. The
results from several independent transfection experiments indicated that VSVs encoding all of the single and two double
mutant P proteins (VSVP60, VSVP62, VSVP64, VSVP60/62,
and VSVP62/64) could be rescued. VSVP60/64, carrying mutations for positions Ser-60 and Ser-64 of the P protein, could
not be rescued even after 10 independent rescue attempts and
also varying the amounts of support plasmid mix used during
transfection. In addition, we attempted to detect VSVP60/64
by passaging the transfected cell supernatant into cells express-

ing the wt P protein in trans, but this attempt failed to detect
any rescued VSVP60/64.
Since the maximal CPE was observed at different times
postinfection with supernatants from transfected cells, we suspected that the supernatants contained various amounts of
infectious VSV. The supernatants from transfected cells were
amplified once in cells to generate a P1 stock virus. To examine
the growth potential of various mutant viruses, we infected
cells with each of the mutant viruses and determined the overall yield of virus by a plaque assay. The results (Fig. 2A) show
that the recovered mutant viruses grew to titers that were
similar to that of wt VSV, indicating that the overall growth
potential of the mutant viruses was not adversely affected by
the phosphorylation status of the encoded P protein. Even
after multiple passages of the transfected cell supernatant, we
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failed to recover virus from cells transfected with pVSVFLP60/
64. VSVPE/E/E, which contained glutamic acid residues in
place of the phosphate acceptor sites in domain I, readily grew
to titers similar to those of other viruses. Taken together, these
results indicate that although the mutant P proteins possessed
different levels of transcriptional activity in minigenome transcription experiments (44, 53), viruses encoding the mutant
proteins, with the exception of VSVP60/64, could be rescued
readily from transfected cells and grew to similar titers.
P protein without phosphorylation in domain I residues
cannot support the rescue of infectious VSV. We had previously observed that a mutant P protein in which the phosphate
acceptor sites Ser-60, Thr-62, and Ser-64 were altered to alanine was significantly defective in supporting transcription of a
minigenome (44). In a separate study (53), it was shown that
this mutant P protein was completely defective in phosphorylation in domain I and possessed low levels of transcriptional
activity compared to the wt P protein. Therefore, we examined
whether this mutant P protein could rescue infectious VSV
from transfected cells. We found that infectious VSV encoding
the mutant P60/62/64 protein could not be rescued from transfected cells. This was observed repeatedly in at least 10 independent transfection experiments under various transfection
conditions. We also attempted to detect the mutant virus by
passaging the transfected cell supernatant into cells expressing
the wt P protein in trans, but such attempts failed to detect
VSVP60/62/64. These results suggest that VSV encoding a P
protein in which all of the phosphate acceptor sites in domain
I are altered to alanine cannot be rescued.
Viruses with mutations in phosphorylation sites in domain
I exhibit similar kinetics of growth and mRNA synthesis. Since
our previous studies demonstrated that mutations within domain I residues result in a significant downregulation of transcription in a minigenome system (44), we were surprised to
observe that VSVs containing these mutant P proteins grew to
similar titers during passaging in cell culture. We examined
whether these mutant viruses had altered growth kinetics under single-cycle growth conditions. The results (Fig. 2B) show
that all of the mutant viruses possessed growth kinetics similar
to those of wt VSV. No significant differences in virus titers
were observed at any particular time postinfection.
To examine mRNA synthesis, we analyzed metabolically
radiolabeled mRNAs in cells infected with various mutant
viruses. Our results showed that the levels of mRNA synthesized in cells infected with VSVP60, VSVP62, and VSVP64
were similar to that synthesized in wt VSV-infected cells (Fig.
2C). Similar results were also obtained with the VSVP60/62,
VSVP62/64, and VSVPE/E/E viruses (not shown). A quantitative analysis indicated that the levels of mRNA synthesis in
cells infected with the mutant viruses were not significantly
different from that in wt VSV-infected cells.
In the studies reported above for the recovery of mutant
viruses, our approach was based on using the plasmid encoding
the wt P protein in the support plasmid mix. It is possible that
vaccinia virus-mediated homologous recombination between
the plasmid containing the wt P coding region used in the
support plasmid mix and the mutant P coding region in the
pVSVFL(⫹) template may have resulted in the generation of
a VSVPwt genome. In such a scenario, viruses recovered from
the above experiments may predominantly contain wt genomes
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FIG. 3. Examination of phosphorylation status of P proteins in
infected cells. Parallel cultures of BHK-21 cells were infected with wt
or mutant viruses. Cells were labeled with [32P]orthophosphate or were
left unlabeled. Equal proportions of cytoplasmic extracts were analyzed by electrophoresis in parallel gels. 32P incorporation into the P
protein (top) was detected by autoradiography. The total P proteins
were examined by Western blotting (bottom). Arrows in the panels
identify P proteins. Numbers at the bottom represent average ratios of
32
P/P from three independent experiments.

and may possess similar growth kinetics and mRNA profiles, as
shown above (Fig. 2B and C). Although our inability to recover
viruses with pVSVFLP60/64 and pVSVFLP60/62/64 suggests
otherwise, nevertheless we examined the sequence of the P
coding region in various mutant viruses. The results in Fig. 2D
show that the introduced mutations were maintained in the
mutant virus genomes. We examined the sequences of all of
the mutant viruses, but only the results for VSVP60, VSVP62,
and VSVP64, along with VSVPwt, are shown. Furthermore,
the RT-PCR-amplified products were cloned, and five clones
of each mutant virus P coding region were sequenced in their
entirety. No other mutations within the P coding region of any
of the mutant viruses were observed. Thus, our results suggest
that single or double mutations in the phosphate acceptor sites
in domain I (with the exception of P60/64) can support replication and growth of VSV.
Phosphorylation status of P protein in mutant virus-infected cells. Previous studies have demonstrated that mutations in phosphate acceptor sites in the P protein alter the
extent of phosphorylation. However, these studies were performed in vitro or in transfected cells ectopically expressing the
mutant P proteins (6, 28). To examine the extent of phosphorylation of P proteins in mutant virus-infected cells, we infected
two parallel sets of cells with various mutant viruses. One set of
infected cells was radiolabeled with [32P]orthophosphate while
the other set was left untreated. Cell lysates were prepared
from both cultures and equal amounts of cell lysates were
analyzed by electrophoresis. The 32P-labeled samples were examined directly by autoradiography to determine the incorporation of phosphates into the P protein, whereas the unlabeled
samples were examined by Western blotting to determine the
total amount of P protein. Our results (Fig. 3) show that the
extents of phosphorylation of the P protein in various mutant
virus-infected cells are different. Interestingly, we observed in
independent repeat experiments that the amount of phosphate
in the P protein of VSVP64 was significantly lower than that
for the other single substitution mutant viruses. It is possible
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FIG. 4. (A) Single-cycle growth kinetics of viruses with substitutions in domain II phosphate acceptor sites. The experiment was performed as
described in the legend for Fig. 2B. Error bars represent standard deviations. (B) Phosphorylation status of P proteins of domain II mutant viruses.
Data were obtained as described in the legend for Fig. 3. Arrowheads in the panels identify P proteins. (C) Kinetics of RNA synthesis in cells
infected with VSVPwt and VSVP227. BHK-21 cells infected with VSVPwt (lanes 1 and 3) or VSVP227 (lanes 2 and 4) at an MOI of 100 (lanes
1 and 2) or 10 (lanes 3 and 4) were radiolabeled with [3H]uridine and [3H]adenosine in the presence of actinomycin D for 1 h at 1 or 7 h postinfection as described in Materials and Methods. Total RNAs were isolated and analyzed by electrophoresis. The positions of full-length as well
as the five VSV mRNAs are indicated on the left. Numbers at the bottom show the average levels of total viral mRNAs from three experiments.
(D) Analysis of viral proteins in cells infected with VSVPwt and VSVP227. BHK-21 cells were infected with VSVPwt (lanes 1 and 3) or VSVP227
(lanes 2 and 4) at an MOI of 100 (lanes 1 and 2) or 10 (lanes 3 and 4). The proteins were radiolabeled with 35S, and equal proportions of cell lysates
were analyzed by electrophoresis as described in Materials and Methods. The positions of the viral proteins are shown on the left. The levels of
viral protein represent average values from three independent experiments.

that the mutation in Ser-64 may affect phosphorylation at other
sites.
VSV with a mutation in the domain II phosphate acceptor
site exhibits reduced kinetics of growth but increased kinetics
of mRNA and protein synthesis. Our previous studies demonstrated that individual mutations in the phosphate acceptor
sites (Ser-226 and Ser-227) did not have any adverse effects on
transcription or replication but that mutations in both of these
sites rendered the protein significantly defective in replication
without affecting its transcription functions (26). Therefore, we
were interested in examining whether VSVs encoding single or
double amino acid substitutions at these sites in the P protein
could be rescued. pVSVFL(⫹) plasmids encoding single or
double amino acid substitutions in Ser-226 and Ser-227 of the
P protein were used to rescue VSV from transfected cells as
described above. We observed that VSVP226 and VSVP227,
containing individual amino acid substitutions, could be rescued readily. Upon passaging, VSVP226 grew to titers similar
to those of VSVPwt, whereas VSVP227 consistently grew to
titers that were about 10-fold lower than those of VSVPwt. The
virus encoding a double mutation (VSVP226/227) could not be
rescued after multiple attempts under various transfection conditions. An analysis of single-cycle growth kinetics suggested
that the VSVP227 virus grows slowly and to lower final titers
than the VSVPwt or VSVP226 virus (Fig. 4A).
An examination of the phosphate incorporation into P proteins (Fig. 4B) showed that the extents of phosphorylation of
the P protein in mutant virus-infected cells were different from

that seen with wt VSV-infected cells. Surprisingly, the P protein of VSVP226 was found to be hyperphosphorylated. The
reason(s) for this is unclear, but it is possible that the mutation
in Ser-226 may have activated other cryptic phosphate acceptor
sites in the P protein. A similar hyperphosphorylation of this
particular mutant P protein has been observed under in vitro
conditions (6).
Since VSVP227 consistently grew to titers about 10-fold
lower than that of VSVPwt, we suspected that VSVP227 had
altered kinetics of mRNA and protein synthesis. To examine
the kinetics of mRNA synthesis, we infected parallel cultures
of cells with an MOI of 100 or 10 and radiolabeled mRNAs at
1 to 2 h or 7 to 8 h postinfection. The rationale for using such
a high MOI was to provide enough templates at the beginning
so that mRNAs could be readily detected at early times after
infection. The results show that all VSV mRNAs as well as the
genomic and antigenomic full-length RNAs could readily be
detected (Fig. 4C). Surprisingly, we observed that the levels of
mRNAs from VSVP227 virus-infected cells were significantly
higher than those produced from VSVPwt virus-infected cells.
This observation was reproducible in multiple independent
experiments. In addition, the synthesis of increased levels of
mRNA in VSVP227 virus-infected cells compared to VSVPwt
virus-infected cells was seen at early (1 to 2 h) or late (7 to 8 h)
times after infection. It should be noted that the total amounts
of genomic and antigenomic RNAs were similar for both
VSVP227 and VSVPwt. A quantitative analysis of the levels of
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mRNAs indicated that VSVP227 synthesizes about a threefold
excess of mRNAs per template compared to VSVPwt.
The above results led us to examine whether increased levels of VSV proteins are synthesized in cells infected with
VSVP227 compared to those infected with VSVPwt. In a similar experiment, we analyzed the levels of VSV proteins in
VSVP227 and VSVPwt virus-infected cells by radiolabeling
them at early and late times after infection. Slightly increased
levels of viral proteins were detected in VSVP227 virus-infected cells compared to those in VSVPwt virus-infected cells
(Fig. 4D).
Taken together, our results suggest that VSVP227, encoding
a mutant P protein, grows to lower titers but produces significantly higher levels of mRNAs in infected cells than does the
wt.
Reduced cytopathogenicity of VSVP227 virus-infected cells.
During our studies, we made an interesting observation with
the VSVP227 virus. Although the formation of distinct plaques
was seen with VSVP227 on monolayers of BHK-21 cells, only
about 25% of the cells in the plaque appeared to have rounded
off and detached, resulting in a partial clearing of the cell
monolayer at the site of plaque formation. This contrasted with
the normal plaque morphology of VSV on BHK-21 cells, in
which ⬎90% of the cells within the plaque show the CPE that
is characteristic of a VSV infection and which normally results
in the almost complete clearance of dead cells at the site of the
plaque.
This observation suggested that VSVP227 is perhaps less
cytopathic in infected cells than is the wt or other mutant
viruses. To examine this, we monitored the development of
CPE over time in BHK-21 cells infected with VSVPwt or
VSVP227. We found that by 12 to 14 h postinfection, infection
with VSVwt resulted in the rounding and detachment of ⬎90%
of the cells in the monolayer (Fig. 5A). However, infection with
VSVP227 resulted in the rounding and detachment of only
about 20 to 30% of the cells. Furthermore, at a low MOI (0.5),
the cell monolayer of wt VSV-infected cells was completely
lost due to a severe CPE by 24 h postinfection, whereas about
50% of the cells in the monolayer of VSVP227-infected cells
still did not show CPE even at 48 h postinfection. Indirect
immunofluorescence studies using anti-VSV antibodies showed
that the majority of cells in the monolayer expressed VSV
proteins (Fig. 5B), indicating that the cells in the monolayer
that appeared normal were supporting replication of
VSVP227.
Since one of the hallmark features of CPE caused by VSV is
the induction of apoptosis (31, 37, 51), we examined the level
of apoptosis in cells infected with VSVPwt or VSVP227. The
results (Fig. 5C) show that about 22% of cells infected with
VSVP227 were undergoing apoptosis compared to about 80%
of cells infected with VSVwt. Taken together, these studies
indicate that VSVP227 exhibits reduced cytopathogenicity in
infected cells.
VSVs encoding various mutant P proteins show various
patterns of RNA synthesis upon high-multiplicity passaging.
Serial undiluted passaging of VSV in cultured cells generates
DI particles containing truncated genomes. The mechanisms
of the generation of DI particles are not known, but host cell
factors as well as viral factors, such as polymerase and the
template, and their interactions are presumed to play a signif-
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FIG. 5. (A) Phase-contrast microscopic images of BHK-21 cells
infected with VSVPwt or VSVP227. BHK-21 cells were infected with
each virus at an MOI of 0.5. At 12 h postinfection, live cells were
observed under a Nikon microscope at a magnification of ⫻20, and
images were processed through a camera (Optronics) attached to the
microscope. (B) Expression of VSV proteins in VSVPwt- or VSVP227infected cells. BHK-21 cells were infected with each virus at an MOI of
0.5 in 12-well plates. At 12 h postinfection, the cells were fixed and
incubated with a mouse anti-VSV polyclonal antibody followed by a
secondary antibody (anti-mouse Alexa-488). The fluorescence was observed at a magnification of ⫻40. The top panel shows cells under
phase-contrast microscopy and the bottom panel shows the same field
under fluorescence microscopy. (C) Quantitative analysis of apoptosis.
BHK-21 cells infected with each virus at an MOI of 0.5 were
trypsinized at 12 h postinfection and stained for apoptotic and necrotic
cells with annexin V-fluorescein isothiocyanate and propidium iodide.
The fluorescing cells were analyzed by flow cytometry, and the means
of three independent experiments are presented, with error bars representing standard deviations.

icant role in the process. Using the panel of VSV mutants with
altered polymerase functions, we were interested to examine
whether the polymerase per se plays a role in the process.
Individual mutant viruses (VSVP60, VSVP62, VSVP64, and
VSVP227) were used to infect BHK-21 cells at an initial MOI
of 10, and equal aliquots of undiluted culture supernatants
were passaged nine successive times in BHK-21 cells. We observed severe CPE in early passages followed by drastically
reduced CPE in later passages. The pattern of increased and
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FIG. 6. Analysis of DI particles generated by high-multiplicity passages of wt or mutant viruses. BHK-21 cells in 60-mm-diameter dishes were
infected with 50 l of undiluted cell culture supernatants from the indicated high-multiplicity passages of wt or mutant viruses. At 2 h postinfection,
the cells were labeled for 4 h with [3H]uridine and [3H]adenosine in the presence of actinomycin D. Cytoplasmic extracts were prepared as
described in Materials and Methods, and one-third of the extracts was used for the isolation of total RNAs. Two-thirds of the extract was incubated
with an anti-VSV antibody to immunoprecipitate the nucleocapsids. Total RNAs (A) or RNAs recovered from immunoprecipitated nucleocapsids
(B) were analyzed by electrophoresis as described above. DI RNAs seen as closely migrating doublets are identified in rectangular boxes. The
positions of full-length genomic and antigenomic (⫹/⫺) RNAs as well as the five VSV mRNAs are indicated on the left.

decreased CPE followed the cyclic nature of a prey-predator
relationship (14, 42), indicating the production of DI particles
in various passages. In initial experiments, culture supernatants
from all passages were used to infect naïve cells and the synthesis of RNAs was examined by metabolic labeling. Several
unique species of DI RNAs were detected in infected cells.
Some DI RNAs appeared early and were lost in late passages,
some remained stable over passages, and others appeared in
late passages and remained stable (data not shown). Figure 6A
shows the pattern of DI RNAs generated by various mutant
VSVs in representative passages. The pattern of DI RNAs for
each of the VSV mutants was unique. Only VSVP62 produced
a DI RNA (lanes 6 and 7) that comigrated with the DI T
genome (lane 1). This particular DI RNA appeared early (passage 3) and was amplified with passaging. The pattern of RNA
species synthesized in cells infected with various passages appeared to be specific for specific mutant viruses since a similar
independent multiple-passage experiment with the mutant viruses resulted in the generation of RNA patterns similar to
those shown in Fig. 6A.
Since these viruses contained mutations in the P protein,
which is involved in both transcription and replication of the
genome, it is possible that some of these truncated RNAs may
have been generated during transcription. The RNA products
generated during transcription do not associate with the viral N
protein, whereas the products of replication are encapsidated

by the N protein and can be specifically immunoprecipitated by
an anti-N protein or anti-VSV antibody. To determine if any of
the truncated RNAs were generated as a result of defects
during transcription of the viral genome, we immunoprecipitated lysates of cells infected with supernatants of various passages and labeled with [3H]uridine and [3H]adenosine with an
anti-VSV antibody. An analysis of the RNAs (Fig. 6B) recovered from immunoprecipitated complexes showed that almost
all of the truncated RNA species were immunoprecipitable
with the anti-VSV antibody, indicating that they are the products of replication. It should be noted that under the gel conditions used here, which separate RNAs based on their size
and adenosine residue content, most RNA species were seen
as closely migrating doublets representing the genomic and
antigenomic RNAs. However, some of the immunoprecipitated RNAs appeared as single species. It is possible that both
genomic and antigenomic RNAs of these DI particles have
similar adenosine residue contents and therefore could not be
resolved from each other.
DISCUSSION
The phosphorylation of viral proteins by cellular or virusassociated kinases is one of the posttranslational modifications
essential for their functioning. The phosphorylation of the
nucleoprotein (N) of rabies virus (55), the VP30 protein of
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Marburg virus (41), and the P proteins of RSV (36) and SeV
(25) plays a role in the transcription and replication of these
viruses. The P protein of VSV has a modular structure. In vitro
studies as well as studies with transfected cells using DI RNAs
or minigenomic RNAs strongly suggest that the phosphorylation of different structural domains of the P protein regulates
its multiple functions in viral genome transcription and replication (2, 3, 7, 8, 16, 17, 26, 44, 53). In the present study, we
addressed the role of P protein phosphorylation in the life
cycle of VSV. Our results suggest that phosphorylation of the
viral P protein is indispensable for the growth of VSV.
Using P proteins with mutations in the phosphate acceptor
sites in domain I, we and others have demonstrated previously
that phosphorylation in this domain is required for the transcriptional activity of the P protein (44, 53). Our inability to
recover infectious virus with a P60/62/64 mutant even after
multiple independent attempts and under various transfection
conditions suggests that the phosphorylation of domain I residues is absolutely critical for virus growth and multiplication.
Our attempts to detect the virus in undiluted supernatants
from transfected cells by plaque assay yielded negative results.
The P60/64 mutant could not rescue infectious VSV, although
it possessed low levels of transcriptional activity in a minigenome assay (44). We suspect that P60/64 is not phosphorylated at all since previous studies have suggested that phosphorylation of Thr-62 requires the prior phosphorylation of
either Ser-60 or Ser-64 (28) and that the phosphate at Thr-62
is prone to dephosphorylation by cellular phosphatases (6).
The lack of rescue of VSV with P60/64 further strengthens our
conclusion that phosphorylation within domain I residues is
absolutely required for the recovery of VSV. These results
differ from those obtained with other negative-strand RNA
viruses, such as RSV and SeV, in that unphosphorylated forms
of the P protein can rescue infectious viruses from cells (25,
36). Our present results, as well as those from previous studies,
suggest that the requirement of phosphorylation of the P protein of VSV for viral genome replication, transcription, and the
generation of infectious viruses is different from that of the
paramyxoviruses studied so far. It would be interesting to examine if the mutant VSVs have altered pathogenic characteristics.
We had previously shown that P proteins with single and
multiple amino acid substitutions (with the exception of P60)
in domain I were ⬍10% active in transcription compared to
the wt P protein (44). Interestingly, all of these mutants (with
the exception of P60/64 and P60/62/64) could support the rescue of VSVs with kinetics of growth and mRNA synthesis that
were similar to those of wt VSV. This observation suggests that
the low levels of transcription supported by these mutant proteins were sufficient to allow the production of infectious
VSVs. It is possible that in these viruses, compensatory mutations in other regions of the P protein may have resulted in a
fully functional protein that could support the growth of VSV.
Sequencing of the P protein coding region from various mutants did not reveal any mutations that could account for the
observed phenotype, although compensatory mutations in the
L and/or N protein have not been ruled out. It is generally
believed that viral proteins are synthesized in a large excess in
virus-infected cells compared to what may be necessary for
growth of the virus. The results presented here suggest that the
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low levels of transcriptional activity of the mutant P proteins
were adequate to support the growth of VSV. At least one of
the phosphate acceptor sites must be phosphorylated for the
protein to be functional in the full-length viral genome. Alternatively, it is possible that the activity of the mutant proteins in
the minigenome transcription and replication system is different from that seen in full-length genomes encoding the mutant
proteins. It will be interesting to determine how the mutant P
proteins become functionally active in the context of a fulllength viral genome.
Our studies with mutants in domain II of the P protein also
suggest that phosphorylation of either Ser-226 or Ser-227 is
essential for the growth of VSV. Our inability to rescue VSV
encoding a P protein with mutations at both of these positions
was not surprising since this protein was shown to be significantly defective in replication (26). Although VSVs with single
amino acid substitutions in this domain of the P protein were
rescued easily, the growth kinetics of VSVP227 were slower
than those of wt VSV. In several independent experiments, we
observed that VSVP227 grew to titers that were about 10-fold
lower than those of wt VSV. More interestingly, VSVP227
synthesized mRNAs that were present, on average, in threefold larger amounts than the wt VSV. Although some increase
in viral proteins was observed in VSVP227-infected cells, proportionately increased amounts of viral proteins were not seen,
indicating that some level of translational control may be operative in VSVP227-infected cells. The reason for the increased synthesis of mRNA is not clear, but it is not due to
elevated levels of full-length templates (Fig. 4C). Sequencing
of the P gene of this virus indicated that no other mutations
were present in the P protein. It is possible that extragenic
mutations in another protein may have been responsible for
this phenotype. Attempts are being made to address this possibility.
Perhaps one of the most interesting aspects of the present
study is the observation that cells infected with VSVP227 exhibited significantly reduced CPE and apoptosis compared to
wt VSV-infected cells (Fig. 5). Rounding and subsequent detachment of the cells, which are characteristics of VSV infections, were substantially reduced. The reason(s) for the reduced cytopathogenicity and apoptosis of VSVP227 is not
known, but it could be due to several factors. Apoptosis in
VSV-infected cells is caused by the direct effects of the M
protein and possibly another viral component (30). This other
component has been suggested to be either the viral doublestranded RNA replication intermediates (10, 34), the leader
RNA (11, 21, 40, 49), or the G protein (13). A role for the P
protein in apoptosis could be envisioned from the results reported here. The introduced mutation at P227 may disrupt the
apoptotic function of the protein, and therefore VSVP227
containing this mutation may induce significantly reduced apoptosis. The viral M protein is known to induce CPE (4, 30)
similar to that seen in VSV-infected cells. Extragenic mutations in the M protein of VSVP227 that disrupt its apoptotic
and CPE-inducing functions may be one of the possible reasons. Alternatively, it is likely that an antiviral state is established in infected cells, leading to reduced cytopathogenicity
and viral titers. In this context, VSVP227 may have acquired
properties to activate NF-B, which is an important mediator
of innate and adaptive host defense mechanisms (18, 35). It
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will be interesting to examine whether NF-B is activated in
VSVP227-infected cells, and if so, whether this activation occurs through interferon-dependent or interferon-independent
pathways. Further work will be needed to determine the mechanism and factors responsible for the conversion of a highly
cytopathic VSV to a mildly cytopathic virus.
Multiple factors control the generation of DI particles in
high-multiplicity passages of VSV. Host cells appear to play a
major role in the process (24). Our observation that mutant
VSVs with altered polymerase functions generated different
sets of DI particles in the same host environment indicates that
the polymerase as well as polymerase-template interactions
due to an altered P protein may also play critical roles in the
process. It is also possible that the alteration of the P protein
affects the host cell environment in a manner that leads to the
generation of different types of DI RNAs. Whether certain
mutant viruses preferentially generate certain types of DI
RNAs (such as the copy-back type or internal deletion type) is
not known. A further characterization of DI RNAs may shed
light into the role of the viral RNA polymerase in generating
specific types of DI RNAs. Previous studies have demonstrated
that an altered replicase specificity results in the resistance of
a VSV mutant (Sdi⫺) to interference by a DI particle (19). In
this regard, it will be interesting to examine whether DI particles generated by one VSV mutant can interfere with the
replication of another VSV mutant. Such studies will provide
insights into an understanding of the selection of viral termini
that are involved in interactions with altered polymerase molecules for the evolution of DI particles during persistent and
acute viral infections.
In conclusion, our studies reported here suggest that the
phosphorylation of residues in the P protein is essential for the
recovery and propagation of infectious VSV. Our results also
suggest that the viral RNA polymerase plays a critical role in
the generation of DI particles. Furthermore, we report that a
VSV with a mutation at Ser-227 in domain II of the P protein
is less cytopathic than the wt VSV, indicating that the P protein
may be involved in cytopathology in infected cells. The molecular basis of the reduced cytopathogenicity of VSVP227 is
currently under investigation.
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